$2.65
-0.20-7.02%
Last update: Nov 10, 7:52 PM
Tilray Brands Inc (TLRY) Stock Price, Quote, News & History
TLRYNASDAQ
Tilray raises FY2027 EBITDA guidance to $70M-$75M and restructures Canadian cannabis operations, targeting $10M in annual savings.
You can purchase shares of Tilray Brands (NASDAQ:TLRY) through any online brokerage.
Other companies in Tilray Brands’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Tilray Brands has a consensus price target of $12.36.
The stock price for Tilray Brands (NASDAQ: TLRY) is $2.6687 last updated November 10, 2026 at 7:52 PM EST.
There are no upcoming dividends for Tilray Brands.
Tilray Brands does not have any upcoming earnings scheduled.
There is no upcoming split for Tilray Brands.
Tilray Brands is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Tilray is a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. The company portfolio includes brand such as Sweet Water Brewing, Montauk Brewing, Brew Dog, Shock Top,...
